Irazuoncology
1 known investors
Irazu Oncology develops cancer immunotherapies based on bacterial outer membrane vesicles, delivering off-the-shelf treatments designed to activate anti-tumor immune responses. The company targets the oncology market with a focus on manufacturing scalability to improve accessibility and affordability.
BiotechHealthtechMedical Devices